These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7512128)

  • 1. Trial of sequential trimetrexate, fluorouracil, and high-dose leucovorin in previously treated patients with gastrointestinal carcinoma.
    Conti JA; Kemeny N; Seiter K; Goker E; Tong W; André M; Ragusa K; Bertino JR
    J Clin Oncol; 1994 Apr; 12(4):695-700. PubMed ID: 7512128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leucovorin enhances cytotoxicity of trimetrexate/fluorouracil, but not methotrexate/fluorouracil, in CCRF-CEM cells.
    Romanini A; Li WW; Colofiore JR; Bertino JR
    J Natl Cancer Inst; 1992 Jul; 84(13):1033-8. PubMed ID: 1376779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimetrexate as biochemical modulator of 5-fluorouracil/leucovorin in advanced colorectal cancer: final results of a randomised European study.
    Punt CJ; Keizer HJ; Douma J; Skovsgaard T; Schüller J; Muller EW; Ten Napel CH; Croles JJ; Lochs H; Zhang J; Hammershaimb L
    Ann Oncol; 2002 Jan; 13(1):81-6. PubMed ID: 11865814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential trimetrexate, 5-fluorouracil and folinic acid are effective and well tolerated in metastatic colorectal carcinoma. The phase II study group of the AIO.
    Szelényi H; Hohenberger P; Lochs H; Haboubi N; Berdel WE; Thiel E; Kreuser ED
    Oncology; 2000 May; 58(4):273-9. PubMed ID: 10838491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double modulation of 5-fluorouracil by trimetrexate and leucovorin in patients with advanced colorectal carcinoma.
    Machiavelli MR; Salum G; Pérez JE; Ortiz EH; Romero AO; Bologna F; Vallejo CT; Lacava JA; Dominguez ME; Leone BA
    Am J Clin Oncol; 2004 Apr; 27(2):149-54. PubMed ID: 15057154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomodulation of 5-fluorouracil with antifolates.
    Bertino JR
    Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-52-S18-56. PubMed ID: 9420021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer.
    Rosati G; Tucci A; Rinaldi A; Colarusso D; Pizza C; Reggiardo G; Manzione L
    Oncology; 2004; 66(5):371-8. PubMed ID: 15331924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer.
    Blanke CD; Shultz J; Cox J; Modiano M; Isaacs R; Kasimis B; Schilsky R; Fleagle J; Moore M; Kemeny N; Carlin D; Hammershaimb L; Haller D
    Ann Oncol; 2002 Jan; 13(1):87-91. PubMed ID: 11863117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of trimetrexate, fluorouracil, and leucovorin for advanced colorectal cancer.
    Blanke CD; Kasimis B; Schein P; Capizzi R; Kurman M
    J Clin Oncol; 1997 Mar; 15(3):915-20. PubMed ID: 9060528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous azidothymidine with fluorouracil and leucovorin: a phase I-II study in previously untreated metastatic colorectal cancer patients.
    Falcone A; Danesi R; Dargenio F; Pfanner E; Brunetti I; Del Tacca M; Nethersell AB; Conte PF
    J Clin Oncol; 1996 Mar; 14(3):729-36. PubMed ID: 8622018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group.
    Valone FH; Friedman MA; Wittlinger PS; Drakes T; Eisenberg PD; Malec M; Hannigan JF; Brown BW
    J Clin Oncol; 1989 Oct; 7(10):1427-36. PubMed ID: 2789272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of a weekly schedule of irinotecan, high-dose leucovorin, and infusional fluorouracil as first-line chemotherapy in patients with advanced colorectal cancer.
    Vanhoefer U; Harstrick A; Köhne CH; Achterrath W; Rustum YM; Seeber S; Wilke H
    J Clin Oncol; 1999 Mar; 17(3):907-13. PubMed ID: 10071283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of overall survival in two randomised studies comparing 5-fluorouracil/leucovorin with or without trimetrexate in advanced colorectal cancer.
    Punt CJ; Blanke CD; Zhang J; Hammershaimb L
    Ann Oncol; 2002 Jan; 13(1):92-4. PubMed ID: 11865815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I study of a combination of allopurinol, 5-fluorouracil and leucovorin followed by hydroxyurea in patients with advanced gastrointestinal and breast cancer.
    Bhalla K; Birkhofer M; Bhalla M; Lutzky J; Hindenburg A; Cole J; Ince C
    Am J Clin Oncol; 1991 Dec; 14(6):509-13. PubMed ID: 1957839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II clinical trial of 5-fluorouracil, trimetrexate, and leucovorin (NFL) in patients with advanced pancreatic cancer.
    Garcia AA; Leichman L; Baranda J; Pandit L; Lenz HJ; Leichman CG
    Int J Gastrointest Cancer; 2003; 34(2-3):79-86. PubMed ID: 15361639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced colorectal carcinoma. A prospective randomized trial of sequential methotrexate, 5-fluorouracil, and leucovorin versus 5-fluorouracil alone.
    Machiavelli M; Leone BA; Romero A; Rabinovich MG; Vallejo CT; Bianco A; Pérez JE; Rodríguez R; Cuevas MA; Alvarez LA
    Am J Clin Oncol; 1991 Jun; 14(3):211-7. PubMed ID: 2031508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952.
    Köhne CH; Wils J; Lorenz M; Schöffski P; Voigtmann R; Bokemeyer C; Lutz M; Kleeberg C; Ridwelski K; Souchon R; El-Serafi M; Weiss U; Burkhard O; Rückle H; Lichnitser M; Langenbuch T; Scheithauer W; Baron B; Couvreur ML; Schmoll HJ;
    J Clin Oncol; 2003 Oct; 21(20):3721-8. PubMed ID: 12963704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I clinical and pharmacologic trial of trimetrexate in combination with 5-fluorouracil.
    Hudes GR; LaCreta F; DeLap RJ; Grillo-Lopez AJ; Catalano R; Comis RL
    Cancer Chemother Pharmacol; 1989; 24(2):117-22. PubMed ID: 2525077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I trial of CPT-11 in combination with 5-fluorouracil plus leucovorin chemotherapy for patients with metastatic colorectal cancer.
    Yamaguchi Y; Minami K; Kawabuchi Y; Emi M
    Hepatogastroenterology; 2006; 53(68):201-5. PubMed ID: 16608024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A weekly 24-h infusion of high-dose 5-fluorouracil (5-FU)+leucovorin and bi-weekly cisplatin (CDDP) was active and well tolerated in patients with non-colon digestive carcinomas.
    Caroli-Bosc FX; Van Laethem JL; Michel P; Gay F; Hendlisz A; Forget F; Bleiberg H
    Eur J Cancer; 2001 Oct; 37(15):1828-32. PubMed ID: 11576835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.